NOVARTIS VACCINES & DIAGNOSTICS INC

Lobbying Spend

—

Filings

Firms Hired

Active Period

2005–2006

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2006	—	6	1
2005	—	1	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
THE DUBERSTEIN GROUP INC.	—	7

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	3
SENATE	3
White House Office	3
Health & Human Services, Dept of (HHS)	1

Most frequently reported lobbying issues

Issue Code	Description	Reports
Pharmacy	Pharmacy	4
Budget/Appropriations	Budget/Appropriations	4
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	3

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

S. 3678109th Congress

Pandemic and All-Hazards Preparedness Act

2006 · year_end · Firm: THE DUBERSTEIN GROUP INC.

Cited source text and reported amounts

Liability, pandemic flu issues, vaccine issues - S 3678, Pandemic and All-Hazards Preparedness Act

Client expense: — · Firm income: $60,000

Matched citations: S 3678

NOVARTIS VACCINES & DIAGNOSTICS INC — Lobbying Disclosure | Poliscope